Ultragenyx Nabs FDA Nod for First Gene Therapy - Ultragenyx Pharmaceutical (NASDAQ:RARE)

Ultragenyx, after FDA speed bump, lands 1st gene therapy nod with green light in glycogen storage disease

If at first you don’t succeed in gene therapy, then try, try again. | If at first you don’t succeed in gene therapy, then try, try again, is the lesson Ultragenyx likely took home this week, pocketing its first FDA nod…